OXAYDO

Peak

oxycodone hydrochloride

NDAORALTABLETPriority Review
Approved
Jun 2011
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
2

Mechanism of Action

mu-opioid receptor, although it can bind to other opioid receptors at higher doses. The principal therapeutic action of oxycodone is analgesia. Like all full opioid agonists, there is no ceiling effect for analgesia with oxycodone. Clinically, dosage is titrated to provide adequate analgesia and…

Indications (3)

acutechronic pain severe enough to require an opioid analgesicfor which alternative treatments are inadequate

Clinical Trials (2)

NCT01571362Phase 3Completed

A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain

Started Jun 2012
410 enrolled
Chronic PainLow Back PainAnalgesia
NCT01428583Phase 3Completed

Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain

Started Dec 2010
395 enrolled
Chronic Noncancer Pain
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers